
Lenacapavir: After FDA approval, HIV pre-exposure prophylaxis injectable moving closer to EU approval
The Hindu
EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.
More Related News

EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.